Volume 4, Issue 4 (Multidisciplinary Cancer Investigation 2020)                   Multidiscip Cancer Investig 2020, 4(4): 1-5 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vasudevan A, Haridas L, Muraleedharan V. Nasopharyngeal Metastasis Originating From Beta-HCG Being Secreting From Transitional Cell Carcinoma of the Renal Pelvis: A Case Report. Multidiscip Cancer Investig 2020; 4 (4) :1-5
URL: http://mcijournal.com/article-1-285-en.html
1- Department of Medical Oncology, Regional Cancer Center, Trivandrum, Kerala, India
2- Department of Radiodiagnosis, Regional Cancer Center, Trivandrum, Ker- ala, India , lakshmiharidasrcc@gmail.com
3- Department of Radiodiagnosis, Regional Cancer Center, Trivandrum, Ker- ala, India
Abstract:   (2209 Views)
Introduction: Transitional cell carcinomas (TCC) of the upper urinary tract constitute only 7% of urothelial carcinomas. The majority of upper urinary tract TCC arises from the renal pelvis, followed by the ureter. The majority of the patients are presented with microscopic or macroscopic haematuria, flank pain, or symptoms due to metastasis; however, it can be asymptomatic in 10-15%.
Case presentation: Here, we report the case of a 58-year-old male who was referred with headache and cranial nerve palsy, later diagnosed with beta-human chorionic gonadotropin (beta-HCG) that was secreted from TCC of the renal pelvis with nasopharyngeal, lung, and brain metastasis.
Conclusion: Nasopharyngeal metastasis from TCC of the renal pelvis is a rare entity and this case report adds to the present literature.
Full-Text [PDF 1039 kb]   (1187 Downloads)    
Select article type: Case Report and Series | Subject: Supportive and Palliative Care
Received: 2020/06/5 | Accepted: 2020/09/21 | ePublished: 2020/10/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb